Sector valuations Monte Rosa Therapeutics, Inc.

Stocks

GLUE

US61225M1027

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2026-09-04 pm EDT			5-day change	1st Jan Change
13.84 ^USD	-3.76%		+3.44%	-11.73%

Aug. 24	Monte Rosa Therapeutics Doses First Patient in Phase 2 Prostate Cancer Study	MT
Aug. 24	Monte Rosa Therapeutics Doses First Patient In MODeFIRe-1 Phase 2 Study Of MRT-2359 In Combination With Apalutamide In Patients With AR Mutation-Positive Metastatic Castration-Resistant Prostate Cancer	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	Price to Book (Y)	PEG (Y)	EV / Sales (Y)	EV / EBITDA (Y)	EV / EBIT (Y)	Dividend Yield (Y)	Capi.($)
MONTE ROSA THERAPEUTICS, INC.	-8.52x	-	-0.03x	-	-	-	-	1.18B
LONZA GROUP AG	33.15x	4.43x	1.24x	5.95x	17.82x	24.93x	0.98%	48.93B
REVOLUTION MEDICINES, INC.	-21.5x	22.2x	-0.33x	245.64x	-23.19x	-21.81x	-.--%	45.01B
IQVIA HOLDINGS INC.	34.48x	6.3x	-36.03x	3.33x	14.35x	21.68x	-.--%	44.07B
BEONE MEDICINES AG	46.93x	7.94x	0.23x	5.41x	29.72x	34.2x	-.--%	40.73B
CELLTRION, INC.	28.42x	2.31x	0.58x	8.6x	21.8x	25.89x	0.4%	33.52B
MEDPACE HOLDINGS, INC.	33.62x	24.12x	2.23x	5.51x	25.02x	26.17x	-.--%	16.5B
EUROFINS SCIENTIFIC SE	24.24x	2.71x	0.7x	2.11x	9.11x	14.11x	1.11%	14.67B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	77.18x	4.57x	-0.34x	4.06x	15.75x	19.35x	-.--%	13.77B
ICON PUBLIC LIMITED COMPANY	27.98x	1.33x	0.27x	1.85x	11.36x	12.93x	-.--%	12.72B
TEMPUS AI, INC.	-46x	23.7x	123.08x	7.63x	186.93x	-2486.48x	-.--%	11.66B
BIO-TECHNE CORPORATION	52.42x	4.57x	2.74x	8.7x	24.69x	29.45x	0.44%	11.36B
ABIVAX	-27.52x	8.1x	1.04x	97.58x	-27.78x	-48.33x	-.--%	9.78B
PHARMARON BEIJING CO., LTD.	37.96x	4.36x	2.45x	4.5x	19.48x	30.97x	0.59%	10.39B
PRAXIS PRECISION MEDICINES, INC.	-25.33x	8.75x	-8.29x	10575.2x	-20.89x	-20.57x	-.--%	9.82B
KYMERA THERAPEUTICS, INC.	-30.32x	8.81x	-6.14x	80.33x	-20.25x	-19.64x	-.--%	9.76B
IONIS PHARMACEUTICALS, INC.	-15.96x	672.49x	-0.3x	10.46x	-16.79x	-16.16x	-.--%	9.65B
PROTAGONIST THERAPEUTICS, INC.	31.33x	-	-0.1x	16.4x	29.92x	29.23x	-.--%	9.43B
QIAGEN N.V.	22.57x	2.4x	-32.17x	4.51x	12.06x	15.41x	0.31%	8.99B
Average	14.48x	47.59x	2.68x	615.99x	17.17x	-129.37x	0.21%	19.05B
Weighted average by Cap.	20.28x	27.18x	-1.11x	328.03x	15.32x	-67.68x	0.25%

Other Biotechnology & Medical Research

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!